Total Funding
53
Total FundingGrant raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
127430
Symphony Biosciences is a biotech company that develops cancer drugs to help treat solid tumors.
About the Company
Symphony Biosciences company is in charge of orchestrating the immune response in the fight against solid cancers. Symphony primary target is triple-negative breast cancer, for which the best current treatments are toxic chemotherapies that simply do not work: survival is poor.
